Fredun Pharmaceuticals Ltd.
Snapshot View

929.40 -0.60 ▼-0.1%

12 August 2022, 04:01:00 PM
Volume: 367

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.fredungroup.com
Market Cap 413.84 Cr.
Enterprise Value(EV) 464.53 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 14.22 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 65.34 Trailing Twelve Months Ending 2022-03
Industry PE 32.02 Trailing Twelve Months Ending 2022-03
Book Value / Share 156.00 Trailing Twelve Months Ending 2022-03
Price to Book Value 5.96 Calculated using Price: 929.40
Dividend Yield 0.08 Period Ending 2021-03
No. of Shares Subscribed 0.45 Cr. 4,452,779 Shares
FaceValue 10
Company Profile
The company is engaged in manufacturing of pharmaceutical products.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.06%
1 Week
-1.55%
1 Month
+7.58%
3 Month
+3.00%
6 Month
-7.28%
1 Year
+135.74%
2 Year
+255.96%
5 Year
+1423.61%
10 Year
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 0.31 9.79 9.68 33.46 33.88 13.02 14.59 4.74 4.77
Return on Capital Employed (%) 12.40 14.50 14.23 24.67 18.16 15.90 20.56 10.36 9.53
Return on Assets (%) 0.05 1.50 1.26 3.23 2.88 2.59 4.84 1.54 1.33

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 3 3 3 4 7 22 39 41 43 68
Non Curr. Liab. 2 3 4 7 8 4 13 14 32 45
Curr. Liab. 10 12 16 32 40 53 53 86 86 74
Minority Int.
Equity & Liab. 15 18 23 43 56 79 105 141 162 187
Non Curr. Assets 7 8 10 15 21 28 32 32 32 34
Curr. Assets 8 10 13 28 35 51 73 109 130 153
Misc. Exp. not W/O 0
Total Assets 15 18 23 43 56 79 105 141 162 187

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 15 21 25 42 57 60 97 113 134 226
Other Income 0 0 0 1 2 0 1 1 1
Total Income 15 22 26 43 59 60 98 113 135 226
Total Expenditure -14 -20 -24 -38 -53 -54 -87 -104 -125 -211
PBIDT 1 2 2 5 5 6 11 9 11 15
Interest -1 -1 -1 -2 -2 -2 -3 -4 -4 -5
Depreciation 0 -1 -1 -1 -1 -1 -1 -2 -2 -2
Taxation 0 0 0 -1 -1 -1 -2 -1 -1 -2
Exceptional Items 0 0 -1
PAT 0 0 0 1 1 2 4 2 2 6
Adjusted EPS 0 1 1 4 5 4 11 5 5 15

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 1 -1 2 3 4 17 1 -11 0
Cash Fr. Inv. -1 -2 -3 -6 -7 -8 -5 -1 -1
Cash Fr. Finan. 0 2 1 3 3 -8 4 14 -1
Net Change 0 0 0 1 -1 1 0 2 -2
Cash & Cash Eqvt 1 0 1 1 1 1 1 3 1

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 52.04 52.04 52.04 52.04 52.04 52.04 51.27 51.27 51.04
Public 47.96 47.96 47.96 47.96 47.96 47.96 48.73 48.73 48.96
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 5.54 5.54 5.54 5.54 5.54 5.54 0.00 0.00 0.00

Announcements View Details >>

Fri, 12 Aug 2022
Financial Results For The Quarter Ended 30Th June 2022
We wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as the Company) at their Meeting held on Friday 12th August 2022 at 3:00 pm had considered and approved the following items of Business:1. In compliance to Regulation 30 and 33 of SEBI Listing Regulations 2015; the Un-Audited Financial Results of the Company for the quarter ended 30th June 2022; along with the Limited Review Report as issued by M/s Savla & Associates; Statutory Auditors of the Company; copies of which are attached hereunder;The Meeting of the Board Commenced at 3:00 P.M. and concluded at 06:50 P.M.Kindly oblige and take the same on your Records.
Fri, 12 Aug 2022
Board Meeting Outcome for Outcome Of Board Meeting Dated 12Th August 2022
We wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as the Company) at their Meeting held on Friday 12th August 2022 at 3:00 pm had considered and approved the following items of Business:1. In compliance to Regulation 30 and 33 of SEBI Listing Regulations 2015; the Un-Audited Financial Results of the Company for the quarter ended 30th June 2022; along with the Limited Review Report as issued by M/s Savla & Associates; Statutory Auditors of the Company; copies of which are attached hereunder;The Meeting of the Board Commenced at 3:00 P.M. and concluded at 06:50 P.M.Kindly oblige and take the same on your Records.
Fri, 05 Aug 2022
Board Meeting Intimation for Board Meeting Of The Company On Friday 12Th August 2022
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 inter alia to consider and approve Pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday 12th August 2022 at 3.00 p.m. at the Corporate Office of the Company to transact inter - alia the following businesses:1) To discuss consider and approve Unaudited Financial Results of the Company for the quarter ended 30th June 2022.2) Any other matter with the permission of the ChairKindly take the same on your records.

Technical Scans View Details >>

Fri, 12 Aug 2022
High Delivery Percentage High Delivery Percentage
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
High Increase 1 Month High Increase 1 Month
High Increase 1 Year High Increase 1 Year
High Increase 2 Years High Increase 2 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 913.45 -0.8%
Divi's Laboratories Ltd. 98,918.90 3,726.20 -5.6%
Cipla Ltd. 82,906.37 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. 51,917.53 1,534.00 -0.1%
Piramal Enterprises Ltd. 45,855.65 1,921.35 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 33.32 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,921.35 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 3.86 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,921.35 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,921.35 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,921.35 +0.8%

FAQ's On Fredun Pharmaceuticals Ltd.

Can I Buy Fredun Pharma Shares now?

What is the Share Price of Fredun Pharma?

What is the Relative Strength Index (RSI) Value of Fredun Pharma?

What is the Market Capital (MCAP) of Fredun Pharma?

What are the key metrics to analyse Fredun Pharma?

What is the Price Performance of Fredun Pharma?